Introduction
Dihexa is a small peptide analogue derived from angiotensin research, studied in laboratory settings as a research compound. This overview covers its structure, synthesis, and in vitro study applications only.
Structure and Synthesis
Dihexa is based on a short modified peptide sequence (an Nle-containing angiotensin IV analogue) produced by chemical synthesis and purified by preparative reversed-phase HPLC. Identity is confirmed by mass spectrometry and purity by analytical HPLC before laboratory use.
In Vitro Study Applications
- Cell culture models examining peptide-analogue interactions with cellular systems
- Receptor and signaling-pathway readouts in controlled laboratory experiments
- Stability and degradation studies in buffer and media conditions
- Analytical method development using a well-characterized reference compound
Analytical Notes
Researchers typically confirm identity by mass spectrometry, purity by RP-HPLC, and net content by amino acid analysis or quantitative methods before use in sensitive assays, since compound quality directly affects reproducibility.
References
Published laboratory literature on angiotensin IV analogues in experimental models; standard peptide synthesis and characterization literature.
Disclaimer
This article is for laboratory research education only. All products referenced are not for human consumption / research use only. No medical, therapeutic, dosing, or efficacy information is provided or implied.